report_id=AMR706 The global bone growth stimulators market is highly competitive, with a number of established players as well as new entrants vying for market share. Key players in the market include ...
Orthofix announced an exclusive license agreement in April 2021 to commercialize IGEA’s bone, soft tissue, and cartilage stimulator product portfolio in the United States and Canada. This agreement ...
Global Bone Growth Stimulator Market is estimated to valued at USD 1.20 Bn in 2024 & expected reach USD 1.71 Bn by 2031, exhibiting CAGR of 5.2% from 2024-2031 ...
Shares of Orthofix Medical Inc. (NASDAQ ... The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive ...
Comparatively, Orthofix Medical has a beta of 1.1 ... The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and ...